Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143875 |
| CAS No | NA |
| Mol.F. | C23H30N2O4 |
| Mol.Wt. | 398.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143876 |
| CAS No | NA |
| Mol.F. | C36H62N2O13 |
| Mol.Wt. | 730.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143877 |
| CAS No | NA |
| Mol.F. | C36H65N3O14 |
| Mol.Wt. | 763.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143878 |
| CAS No | NA |
| Mol.F. | C36H64N2O14 |
| Mol.Wt. | 748.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143879 |
| CAS No | NA |
| Mol.F. | C9H12N2O3 |
| Mol.Wt. | 196.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143880 |
| CAS No | NA |
| Mol.F. | C25H21N5O5 |
| Mol.Wt. | 471.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143881 |
| CAS No | NA |
| Mol.F. | C28H28N6O5 |
| Mol.Wt. | 528.57g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143882 |
| CAS No | NA |
| Mol.F. | C12H13N3O2 |
| Mol.Wt. | 231.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143883 |
| CAS No | NA |
| Mol.F. | C11H18N6O3S2 |
| Mol.Wt. | 346.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143884 |
| CAS No | NA |
| Mol.F. | C4H8N4O3 |
| Mol.Wt. | 160.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143885 |
| CAS No | NA |
| Mol.F. | C4H7N3O3S |
| Mol.Wt. | 177.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143886 |
| CAS No | NA |
| Mol.F. | C12H20N6O4S2 |
| Mol.Wt. | 376.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143887 |
| CAS No | NA |
| Mol.F. | C11H17N5O4S2 |
| Mol.Wt. | 347.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143888 |
| CAS No | NA |
| Mol.F. | C15H24N8O5S3 |
| Mol.Wt. | 492.59 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143889 |
| CAS No | NA |
| Mol.F. | C20H32N8O3S4 |
| Mol.Wt. | 560.77 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143890 |
| CAS No | NA |
| Mol.F. | C11H19N5O2S2 |
| Mol.Wt. | 317.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |